Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease
Circulation Cardiovascular Quality and Outcomes2012Vol. 5(6), pp. 819–829
Citations Over TimeTop 1% of 2012 papers
Lu Wang, Yiqing Song, JoAnn E. Manson, Stefan Pilz, Winfried März, Karl Michaëlsson, Annamari Lundqvist, Simerjot K Jassal, Elizabeth Barrett‐Connor, Cuilin Zhang, Charles B. Eaton, Heidi T. May, Jeffrey L. Anderson, Howard D. Sesso
Abstract
This meta-analysis demonstrated a generally linear, inverse association between circulating 25(OH)-vitamin D ranging from 20 to 60 nmol/L and risk of CVD. Further research is needed to clarify the association of 25(OH)-vitamin D higher than 60 nmol/L with CVD risk and assess causality of the observed associations.
Related Papers
- → Effects and safety of separate low-dose hydrocortisone use in patients with septic shock: A meta-analysis(2019)2 cited
- → Confounding: What It Is and What Can Be Done(2006)2 cited
- Evaluating the role of confounding in pharmacoeconomic studies.(2003)
- → The Problem of Confounding(2016)
- → Confounding Effect in Clinical Research of Otolaryngology and Its Control(2015)